Crossmark

Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries

Published Online: 2024-05-18

Published Print: 2024-08

Authors

Rujkijyanont, Piya https://orcid.org/0000-0002-5006-9810
Inaba, Hiroto https://orcid.org/0000-0003-0605-7342
License Information

Text and Data Mining valid from 2024-05-18

Version of Record valid from 2024-05-18
More Information

Article History

Received: 13 March 2024

Revised: 30 April 2024

Accepted: 2 May 2024

First Online: 18 May 2024

Competing interests

: HI receives research grants from Servier, Amgen, and Incyte and consulting fees from Jazz Pharmaceuticals, Servier, and Amgen. PR has nothing to declare.

Document is current